Custirsen Completed Phase 1 Trials for Brain and Central Nervous System Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00074243CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas